xbizo Posted - 1 day ago

$CDXS finishing with a new 52 week high should attract some attention.

nastento Posted - 1 day ago

$CDXS beautiful

valueforme Posted - 1 day ago

$CDXS Soon

IvansDrivin Posted - 1 day ago

$CDXS anyone know what's driving the price action here? Long since 1.70 but not sure if I should add or sell. Thanks!

valueforme Posted - 2 days ago

$CDXS Dilly: "Bachem is one of the potential GMP scaling partners" $BCHMY

valueforme Posted - 2 days ago

$CDXS Codexis is becoming the flagship of green chemistry in oligos pharma manufacturing. Do not underestimate this. E.g. here is a screenshot from the $ALNY corporate responsibility

TheHowlingMadness Posted - 3 days ago

$CDXS gorgeous

TheHowlingMadness Posted - 4 days ago

$CDXS gorgeous day

xbizo Posted - 4 days ago

@Astondb9 $CDXS seems to track with $MYO too. Weird. Completely different businesses, although at similar stages of development.

valueforme Posted - 4 days ago

$CDXS Stifel notes after the conference today

TheHowlingMadness Posted - 4 days ago

$CDXS 5 bucks this week?

nastento Posted - 5 days ago

$CDXS this baby's been strong even with market conditions. Can we finally hear who the early access companies are??

valueforme Posted - 5 days ago

$CDXS

valueforme Posted - 1 week ago

$CDXS I'm going to make a prediction - the deal that Dilly was talking about I'd going to be with $SLN Zerlasiran ended phase 2, Divesiran ended phase 1 . Zerlasiran is a potential blockbuster with huge addressable population . Silence Therapeutics is not Alnylam or Novartis. They don't have manufacturing capabilities for such drug if it's successful. They'd better to go enzymatic siRNA manufacturing route as early as possible and incorporate this into their CMC strategy for future FDA interactions

valueforme Posted - 1 week ago

$CDXS Holds well on the bloody day. Roadshow next week should lead to analyst upgrades. And of course we still missing news on this commercial contract with a "major siRNA innovator". Holding and adding a bit.

MnegoitaM Posted - 1 week ago

$CDXS good news, he tripped and fell

N808 Posted - 1 week ago

@WantedToRetireEarly $CDXS is also making progress with a stable slowly growing established and profitable business and potentially massive upside with their RNA manufacturing platform

LongCut Posted - 1 week ago

$CDXS They synthesized Inclisirin (LEQVIO), which is not available as a generic…meaning they are working with Novartis

valueforme Posted - 1 week ago

$CDXS Commercial contract with a "major siRNA innovator" is being finalized.

valueforme Posted - 1 week ago

$CDXS

valueforme Posted - 1 week ago

$ALNY $NVS $CDXS I told ya - inclisiran

LongCut Posted - 1 week ago

$CDXS Expecting a trove of positive news at tonight’s conference call. No reason to have a call after a big industry meeting unless they have good news to share.

TheHowlingMadness Posted - 1 week ago

$CDXS

MN009 Posted - 1 week ago

$CDXS I was expecting the share price of $CDXS to go up today following TIDE Europe. Not so. Who knows what happened ?

Fingerlickengood Posted - 1 week ago

$CDXS $JNJ $PFE $GSK Read his Bio...this is what he does! https://www.bloomburton.com/finalist-member/stephen-dilly/

Fingerlickengood Posted - 1 week ago

$CDXS I think soon we will see this reach the stars! Like I've posted before, Dilly was brought to Codexis by the BoD for one reason and one reason only. Flip the company then sell it for a small fortune! The man has done it multiple times before and he left retirement to come to Codexis! This will be sold for around $3B when the time comes, you can to do the math and see what share price we're talking....I don't think they will need to achieve positive cash flow first either, only show that they are on the path to it! Hold on to your hats! $JNJ $PFE $RHHBY

valueforme Posted - 1 week ago

$CDXS Do we have any boots on the ground at Tides EU? Miller's presentation on enzymatic ligation was today: "The presentation will include real customer case studies stemming from our RNA Ligase Screening & Optimization Services, which launched in May of this year. " Of course tomorrow presentation about fully enzymatic synthesis of a real commercial oligo is more interesting.

TheHowlingMadness Posted - 1 week ago

$CDXS here we go

nastento Posted - 1 week ago

$PRQR $CDXS and $SGMT makes my profile look great

MnegoitaM Posted - 1 week ago

$CDXS REDWOOD CITY, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Raymond De Vré, PhD, to the Company’s Board of Directors.